TABLE 4.
Long-term pp65-2 cellular responses postchallenge
| Vaccinated group and monkey | Wk post-RhCMV challenge | % pp65-2-specific T lymphocytesa
|
|
|---|---|---|---|
| CD8+ | CD4+ | ||
| I | |||
| 1 | 16 | 0.05 | 0.02 |
| 24 | 0.13 | 0.14 | |
| 2 | 16 | 0.13 | 0.02 |
| 24 | 0.05 | 0 | |
| 3 | 16 | 0.05 | 0.04 |
| 24 | 0.15 | 0.04 | |
| 4 | 16 | 0.01 | 0.02 |
| 24 | 0.04 | 0 | |
| II | |||
| 5 | 16 | 0.53 | 0 |
| 24 | 0.30 | 0.03 | |
| 6 | 16 | 0.45 | 0.02 |
| 24 | 0.34 | 0.07 | |
| 7 | 16 | 0.06 | 0 |
| 24 | 0.18 | 0.05 | |
| 8 | 16 | 0.01 | 0 |
| 24 | 0.07 | 0.01 | |
| Control | |||
| 9 | 16 | 0 | 0 |
| 24 | 0.03 | 0.01 | |
| 10 | 16 | 0 | 0 |
| 20 | 0 | 0.01 | |
| 11 | 16 | 0 | 0 |
| 20 | 0 | 0 | |
| 12 | 16 | 0.08 | 0.01 |
| 24 | 0 | 0 | |
a
Frequency of CD8+ and CD4+ T lymphocytes responding to pp65-2 stimulation. Values are shown after subtraction of background with unstimulated PBMC. Values of >0.08% were considered positive.